2.180SEK-6.03%Mkt Cap: 50.62M $P/E: —1d ago
Enzymatica AB (publ), a life science company, develops and sells medical devices for infectious diseases. The company's product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that ca…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap50.62M $
Enterprise Value51.44M $
Revenue (TTM)5.08M $
Gross Profit3.17M $
Net Income (TTM)-4.96M $
Revenue/Share0.0209 USD
Last Price2.180 SEK
Fiscal Year EndMar 2021
MR QuarterMar 2026
Employees21
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0003943620
Valuation
P/E (Trailing)—
P/E (Forward)-7.27
PEG—
EV/EBITDA-12.09
EV/Revenue10.13
P/S9.97
P/B4.77
EPS (TTM)-0.20
EPS (Forward)-0.30
52W Range
1.60032% of range3.400
52W High3.400 SEK
52W Low1.600 SEK
Profitability
Gross Margin61.45%
Oper. Margin-118.64%
EBITDA Margin-83.82%
Profit Margin-96.27%
ROE-41.79%
ROA-36.55%
Growth
Revenue Growth-6.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.92M $
CapEx (TTM)22.10K $
FCF Margin-41.85%
FCF Yield-4.20%
Net Debt-2.43M $
Net Debt/EBITDA0.57
Balance Sheet
Debt/Equity0.01
Current Ratio3.05
Quick Ratio2.09
Book Value/Sh0.4570 SEK
Cash/Share0.1070 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.242.74M
Float106.48M
Insiders63.16%
Institutions9.85%
Technical
SMA 502.523 (-13.6%)
SMA 2002.230 (-2.2%)
Beta-0.38
S&P 52W Chg19.63%
Avg Vol (30d)68.87K
Avg Vol (10d)43.76K
Technical Indicators
RSI (14)38.4
MACD-0.0663
MACD Signal-0.0555
MACD Hist.-0.0108
BB Upper2.592 SEK
BB Middle2.380 SEK
BB Lower2.168 SEK
BB Width17.82%
ATR (14)0.1908 SEK
Vol Ratio (20d)1.33x